CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Limited, often referred to as CSPC, is a prominent player in the global pharmaceutical industry, headquartered in the United States. Founded in 1997, the company has established a strong presence in major operational regions, including Asia and Europe, focusing on the research, development, manufacturing, and marketing of a diverse range of pharmaceutical products. CSPC is renowned for its innovative core offerings, which include prescription medications, over-the-counter drugs, and active pharmaceutical ingredients. The company’s commitment to quality and research excellence has positioned it as a leader in therapeutic areas such as oncology, cardiovascular health, and central nervous system disorders. With numerous accolades and a robust market position, CSPC continues to make significant strides in advancing healthcare solutions worldwide.
DitchCarbon Score
How does CSPC Pharmaceutical Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CSPC Pharmaceutical Group Limited's score of 3 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CSPC Pharmaceutical Group Limited's reported carbon emissions
CSPC Pharmaceutical Group Limited, headquartered in the US, reported its carbon emissions data for the year 2017. The company has not disclosed specific absolute emissions figures in kg CO2e for that year. However, it has provided various intensity metrics related to its operations, including steam consumption intensity at approximately 0.0837 tonnes per HK$100 million income, electricity consumption intensity at about 0.0041 million kWh per HK$100 million income, and coal consumption intensity at around 0.000458 tonnes per HK$100 million income. Currently, CSPC Pharmaceutical Group has not set any formal reduction targets or commitments under the Science Based Targets initiative (SBTi) nor does it have a climate pledge in place. This indicates a potential area for improvement in their climate strategy, especially as the pharmaceutical industry increasingly focuses on sustainability and carbon footprint reduction. As the company continues to operate, it may benefit from establishing clear emissions reduction goals and enhancing transparency regarding its carbon footprint to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CSPC Pharmaceutical Group Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
